PsiThera
2 known investors
PsiThera is a biotechnology company using computational and physics-based methods—including quantum mechanics, molecular dynamics, machine learning, and simulation—for mechanism-driven drug design and discovery. Its work spans computational chemistry, immunology, and translational research to advance novel therapeutics.
Investors · 2
Funding
SEC filings, press & company announcements- Undisclosed amountSeries ADec 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 3
by search overlapRayThera15 shared keywordsRayThera develops small molecule therapies targeting unmet needs in immunology. The company focuses on drug discovery in the biotechnology and immunology space.
Spyre Therapeutics13 shared keywordsSpyre Therapeutics is a clinical-stage biotechnology company developing antibody therapies for immunology, aiming for more complete disease control, greater durability, and simpler treatment. Its pipeline targets validated mechanisms to treat gastrointestinal and rheumatic conditions in patients.
Bioworld13 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with PsiThera for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does PsiThera do?
- PsiThera is a biotechnology company using computational and physics-based methods—including quantum mechanics, molecular dynamics, machine learning, and simulation—for mechanism-driven drug design and discovery. Its work spans computational chemistry, immunology, and translational research to advance novel therapeutics.
- Who are PsiThera's investors?
- PsiThera's investors include Lightstone Ventures, Samsara BioCapital.